Lepore, Domenico
 Distribuzione geografica
Continente #
EU - Europa 1.078
NA - Nord America 999
AS - Asia 166
AF - Africa 3
SA - Sud America 1
Totale 2.247
Nazione #
US - Stati Uniti d'America 992
DE - Germania 465
SE - Svezia 187
CN - Cina 107
IT - Italia 90
UA - Ucraina 87
FR - Francia 81
IE - Irlanda 46
GB - Regno Unito 42
FI - Finlandia 36
IN - India 31
BE - Belgio 15
IR - Iran 10
TR - Turchia 10
RU - Federazione Russa 7
PH - Filippine 5
GR - Grecia 4
PL - Polonia 4
ES - Italia 3
MX - Messico 3
NL - Olanda 3
PT - Portogallo 3
CA - Canada 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
AE - Emirati Arabi Uniti 1
AT - Austria 1
BD - Bangladesh 1
CH - Svizzera 1
CL - Cile 1
CR - Costa Rica 1
EG - Egitto 1
JP - Giappone 1
PA - Panama 1
RO - Romania 1
Totale 2.247
Città #
Chandler 267
Ann Arbor 56
Jacksonville 55
San Mateo 49
Ashburn 48
Dublin 44
Marseille 39
New York 38
Nanjing 29
Milan 27
Boston 25
Wilmington 22
Nanchang 21
Helsinki 20
Princeton 20
Woodbridge 20
Dearborn 19
Cattolica 18
Nürnberg 17
Brussels 15
Houston 15
Redmond 14
Munich 13
Augusta 12
Fairfield 12
Pune 11
Beijing 10
Lancaster 9
Lawrence 9
Rome 9
Andover 8
Izmir 8
Los Angeles 8
Bremen 6
Detroit 6
Hebei 6
Leawood 6
Redwood City 6
Seattle 6
Hangzhou 5
Kish 5
Shenyang 5
University Park 5
Busto Arsizio 4
Fremont 4
Kunming 4
Boardman 3
Changchun 3
Fuzhou 3
Kraków 3
Shanghai 3
Tianjin 3
Changsha 2
Columbus 2
Jiaxing 2
Monmouth Junction 2
Mountain View 2
Norwalk 2
Novosibirsk 2
Orta di Atella 2
Pavia 2
Santa Clara 2
Taizhou 2
Washington 2
Ardabil 1
Atlanta 1
Baotou 1
Berlin 1
Bilgi 1
Bologna 1
Brdo 1
Brno 1
Cairo 1
Cambridge 1
Clearwater 1
Cormeilles-en-Parisis 1
Costa Mesa 1
Dhaka 1
Dubai 1
Edinburgh 1
Haikou 1
Hanover 1
Hefei 1
Jinan 1
Kerman 1
Landshut 1
Liverpool 1
Madrid 1
Marietta 1
Mexico 1
Moscow 1
Mumbai 1
Ningbo 1
Overland Park 1
Paris 1
Philadelphia 1
Pisa 1
Portland 1
Pullach im Isartal 1
Sacramento 1
Totale 1.133
Nome #
Cortical visual function in preterm infants in the first year. 203
Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings 154
Visual function at 35 and 40 weeks' postmenstrual age in low-risk preterm infants. 152
Effectiveness of Ketorolac Tromethamine in Prevention of Severe Retinopathy of Prematurity. 142
Occipital porencephaly in a child with gyrate atrophy of the choroid and retina. 136
Analysis of risk factors for progression to treatment-requiring ROP in a single neonatal intensive care unit: is the exposure time relevant? 127
Chronic taaurine supplementation ameliorates oxidative stress and Na+ K+ ATPase impairment in the retina of diabetic rats 102
Phenylephrine eye drops in pediatric patients undergoing ophthalmic surgery: incidence, presentation, and management of complications during general anesthesia 102
A cost effectiveness analysis of cataract surgery 94
An epidemiological analysis of retinopathy of prematurity over 10 years. 91
Why Should We Monitor (1-3)- -D-Glucan Levels during Invasive Candidiasis? Just Ask Your Ophthalmologist! 90
Atlas of fluorescein angiographic findings in eyes undergoing laser for retinopathy of prematurity 87
Phenylephrine eye drops in pediatric patients undergoing ophthalmic surgery: Incidence, presentation, and management of complications during general anesthesia 82
Analysis of risk factors for progression to treatment-requiring ROP in a single neonatal intensive care unit: is the exposure time relevant? 74
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 66
Early visual and neuro-development in preterm infants with and without retinopathy 66
Follow-up to Age 4 Years of Treatment of Type 1 Retinopathy of Prematurity Intravitreal Bevacizumab Injection versus Laser: Fluorescein Angiographic Findings 65
Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist! 59
Retinopathy of Prematurity Reactivated 28 Months after Injection of Ranibizumab 47
Functional and morphologic findings at four years after intravitreal bevacizumab or laser for type 1 ROP 44
Transfusion-Free Survival Predicts Severe Retinopathy in Preterm Neonates. 43
The role of retinal imaging in the management of abusive head trauma cases 40
Effect of topical antiinflammatory drugs on mechanical behavior of rabbit cornea 37
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled trial 32
Re: Lepore et al.: Follow-up to age 4 years of treatment of type 1 retinopathy of prematurity intravitreal bevacizumab injection versus laser: fluorescein angiographic findings (Ophthalmology. 2018;125:218-226) REPLY 32
Re: Lepore et al.: Intravitreal bevacizumab versus laser treatment in type 1 retinopathy of prematurity: report on fluorescein angiographic findings (Ophthalmology 2014;121:2212-9) Reply 31
Convolutional neural network based on fluorescein angiography images for retinopathy of prematurity management 30
Bilateral fixed mydriasis reversible during orthopedic surgery in the prone position 29
Re: Yu et al.: Releasable encircling band for primary rhegmatogenous retinal detachment (Ophthalmology 2014;121:2504-5) 27
Totale 2.284
Categoria #
all - tutte 7.331
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.331


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201947 0 0 0 0 0 0 0 0 0 9 20 18
2019/2020290 55 16 31 7 19 32 28 10 18 21 33 20
2020/2021211 4 22 0 18 23 10 25 8 32 12 51 6
2021/2022265 25 20 2 12 10 5 3 59 16 14 33 66
2022/2023706 83 123 64 87 49 80 51 50 85 9 17 8
2023/2024215 20 75 23 11 5 57 14 3 5 2 0 0
Totale 2.284